More than 40,000 people could benefit after NICE recommends new ‘take at home’ pill for advanced prostate cancer
Thousands of people could benefit from a new oral hormone therapy for advanced hormone sensitive prostate cancer.
Thousands of people could benefit from a new oral hormone therapy for advanced hormone sensitive prostate cancer.
A digital technology that will help healthcare professionals provide a quicker diagnosis to people with attention deficit hyperactivity disorder (ADHD) can be used by the NHS, NICE has said in draft guidance.
More than 20 pieces of draft and final guidance on a range of medicines and medical conditions were published during the pre-election period.
NHS patients in England will benefit from faster access to the most innovative and cutting-edge medical technologies under new plans.
The Spanish Ministry of Health needs to ensure that digital health technologies adopted by the Spanish National Health Service are clinically safe, effective and offer value to the taxpayer. Find out how NICE International has helped them to do this.
As NICE celebrates its 25th anniversary, we look back on its journey from its humble beginnings in 1999. We explore NICE's role and the wide-ranging impact it has had on health and care. And we provide a summary of the organisational changes NICE is making to ensure it continues to add value to an evolving health and care system.
This International Women’s Day, we’re focusing on the invaluable contributions of 2 of the women who help shape our guidance through their independent voluntary committee roles. They talk to us about their involvement with NICE and what #InspireInclusion means to them.
Melanie explains how the update to our quality standard on the transition from children’s to adults’ services will benefit young people, their families and carers.